Dai, Congxin

Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. [electronic resource] - International journal of cancer Oct 2013 - 1982-93 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-0215

10.1002/ijc.28199 doi


Animals
Antineoplastic Agents, Alkylating--pharmacology
Apoptosis--drug effects
Caspase 3--metabolism
Caspase 7--metabolism
Caspase 9--metabolism
Cathepsin B--biosynthesis
Cell Cycle Checkpoints--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Cytochromes c--metabolism
DNA Damage
Dacarbazine--analogs & derivatives
Drug Synergism
Female
Folic Acid Antagonists--pharmacology
Histones--metabolism
Leucovorin--pharmacology
Matrix Metalloproteinase 2--biosynthesis
Matrix Metalloproteinase 9--biosynthesis
Mice
Mice, Inbred NOD
Mice, SCID
Mitochondria--drug effects
Neoplasm Invasiveness
Neoplasm Transplantation
Phosphorylation--drug effects
Pituitary Neoplasms--drug therapy
Poly (ADP-Ribose) Polymerase-1
Poly(ADP-ribose) Polymerases--metabolism
Proto-Oncogene Proteins c-bcl-2--biosynthesis
Pyrimethamine--pharmacology
Rats
Temozolomide
Up-Regulation--drug effects
Xenograft Model Antitumor Assays
bcl-2-Associated X Protein--biosynthesis